CLINICAL_TRIALS
ClinicalTrials.gov record update
A Double-blind,Randomized, Placebo-controlled Study to Assess Exercise Tolerance After Iron Repletion With Ferric Derisomaltose (Monoferric®) IV Compared to Placebo in Heart Failure With Preserved Ejection Fraction and With Iron Deficiency.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04945707
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-09-05T00:02:14.582210+00:00
- Published At
- 2026-09-04T00:00:00+00:00
- Record Updated At
- 2026-09-04
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Iron-deficiency", "Heart Failure With Preserved Ejection Fraction"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-09-04"- protocolSection.identificationModule.nctId
"NCT04945707"- protocolSection.identificationModule.officialTitle
"A Double-blind,Randomized, Placebo-controlled Study to Assess Exercise Tolerance After Iron Repletion With Ferric Derisomaltose (Monoferric\u00ae) IV Compared to Placebo in Heart Failure With Preserved Ejection Fraction and With Iron Deficiency."- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2", "PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.